In Both Hypertrophic And Dilated Cardiomyopathy, Non-contrast T1 Mapping Provides Myocardial Tissue Characterization Beyond That Achieved By Late Gadolinium Enhancement.

In Both Hypertrophic And Dilated Cardiomyopathy, Non-contrast T1 Mapping Provides Myocardial Tissue Characterization Beyond That Achieved By Late Gadolinium Enhancement.

Bibliographic Details
Main Authors:	Dass, S, Suttie, J, Piechnik, S, Ferreira, V, Holloway, C, Karamitsos, T, Robson, M, Watkins, H, Neubauer, S
Format:	Conference item
Published:	2011

Similar Items

Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy.
by: Dass, S, et al.
Published: (2012)

Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy.
by: Dass, S, et al.
Published: (2012)

Response to letter regarding article, "myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy".
by: Dass, S, et al.
Published: (2013)

Cardiac Steatosis Detected in Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy and Aortic Stenosis
by: Suttie, J, et al.
Published: (2011)

Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy.
by: Karamitsos, T, et al.
Published: (2013)

Derangement of cardiac energy metabolism is acutely exacerbated during exercise in hypertrophic cardiomyopathy, independent of hypertrophy or late gadolinium burden
by: Dass, S, et al.
Published: (2012)

ACUTE DERANGEMENT OF CARDIAC ENERGY METABOLISM AND OXYGENATION DURING STRESS IN HYPERTROPHIC CARDIOMYOPATHY-A POTENTIAL MECHANISM FOR SUDDEN CARDIAC DEATH
by: Dass, S, et al.
Published: (2012)

Myocardial dysfunction in hypertrophic cardiomyopathy.
by: Ashrafian, H, et al.
Published: (2001)

Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy
by: Rayner, JJ, et al.
Published: (2020)

Identification of myocardial disarray in patients with hypertrophic cardiomyopathy and ventricular arrhythmias
by: Ariga, R, et al.
Published: (2019)

The role of cardiac energy metabolism and during stress in hypertrophic and dilated cardiomyopathy.
by: Dass, S
Published: (2012)

Patients with hypertrophic cardiomyopathy (HCM) and HCM gene carriers have attenuated myocardial oxygenation response to vasodilator stress - a potential mechanism for sudden cardiac death.
by: Dass, S, et al.
Published: (2012)

Diffusion tensor magnetic resonance imaging of myocardial disarray in hypertrophic cardiomyopathy
by: Ariga, R, et al.
Published: (2018)

Correlates of myocardial fibrosis in hypertrophic cardiomyopathy
by: Kramer, CM, et al.
Published: (2018)

Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies.
by: Watkins, H
Published: (2003)

Further refining risk in hypertrophic cardiomyopathy with late gadolinium enhancement by CMR
by: Kramer, C, et al.
Published: (2018)

Adenosine stress T1 mapping: a novel contrast free method to assess myocardial perfusion and ischaemia in hypertrophic cardiomyopathy
by: Raman, B, et al.
Published: (2017)

Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications
by: Raman, B, et al.
Published: (2018)

Exercise acutely exacerbates derangement of cardiac energy metabolism in hypertrophic cardiomyopathy, a 31 phosphorus magnetic resonance study at 3 Telsa
by: Dass, S, et al.
Published: (2015)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
by: Hudsmith, L, et al.
Published: (2006)

Non-invasive imaging of myocardial disarray associates with ventricular arrhythmia in hypertrophic cardiomyopathy
by: Ariga, R, et al.
Published: (2017)

The Prognostic Value of Late Gadolinium Enhancement CMR in Nonischemic Cardiomyopathies
by: Karamitsos, T, et al.
Published: (2013)

The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies.
by: Karamitsos, T, et al.
Published: (2013)

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
by: Ashrafian, H, et al.
Published: (2003)

Toward replacing late gadolinium enhancement with artificial intelligence virtual native enhancement for gadolinium-free cardiovascular magnetic resonance tissue characterization in hypertrophic cardiomyopathy
by: Zhang, Q, et al.
Published: (2021)

Comparison of the functional effects of mutations in troponin T which cause dilated and hypertrophic cardiomyopathies
by: Robinson, P, et al.
Published: (2002)

Regression of dilated-hypokinetic hypertrophic cardiomyopathy by biventricular cardiac pacing.
by: Ashrafian, H, et al.
Published: (2007)

[Abnormal tropomyosin function in ATPase cycle in hypertrophic and dilated cardiomyopathies].
by: Borovikov, I, et al.
Published: (2013)

Metabolomics in hypertrophic cardiomyopathy and other myocardial diseases
by: Pal, N
Published: (2015)

Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents
by: Ferreira, V, et al.
Published: (2014)

Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents.
by: Ferreira, V, et al.
Published: (2014)

Sudden death in hypertrophic cardiomyopathy.
by: Watkins, H
Published: (2000)

Exercise training in dilated cardiomyopathy improves rest and stress cardiac function without changes in cardiac high energy phosphate metabolism.
by: Holloway, C, et al.
Published: (2012)

Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy
by: Coleman, JA, et al.
Published: (2023)

Metabolic imaging in dilated cardiomyopathy
by: Neubauer, S
Published: (2011)

Dilated cardiomyopathy and the desmin gene.
by: Mayosi, B, et al.
Published: (2000)

The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies topical collection on cardiac PET, CT, and MRI
by: Karamitsos, T, et al.
Published: (2013)

A novel mutation in phospholamban causes a mixed hypertrophic and dilated cardiomyopathy phenotype with autosomal dominant inheritance
by: Carballo, S, et al.
Published: (2004)

Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect
by: Tadros, R, et al.
Published: (2021)

Metabolic perturbations in the pathogenesis of hypertrophic cardiomyopathy
by: Ashrafian, H, et al.
Published: (2005)